Global Financial Private Capital’s iShares Biotechnology ETF IBB Stock Holding History

Global Financial Private Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$14K	Buy	100 +93	+1,329%	+$11.9K	﹤0.01%	294
2020 Q1	$1K	Hold	7	–	–	﹤0.01%	362
2019 Q4	$1K	Hold	7	–	–	﹤0.01%	373
2019 Q3	$1K	Sell	7 -172	-96%	-$18K	﹤0.01%	362
2019 Q2	$20K	Buy	+179	New	+$19K	﹤0.01%	348
2018 Q4	–	Sell	-3,845	Closed	-$469K	–	407
2018 Q3	$469K	Buy	3,845 +1,168	+44%	+$138K	0.02%	388
2018 Q2	$294K	Sell	2,677 -789	-23%	-$84.4K	0.01%	456
2018 Q1	$370K	Sell	3,466 -494	-12%	-$54.8K	0.01%	411
2017 Q4	$423K	Buy	3,960 +312	+9%	+$33.4K	0.01%	371
2017 Q3	$406K	Buy	+3,648	New	+$390K	0.01%	353

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Global Financial Private Capital's IBB Position: Q2 2020 in Review

Global Financial Private Capital increased its iShares Biotechnology ETF (IBB) stake by 1,329% in Q2 2020, buying an estimated $11.9K and bringing the position to 100 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #294.

Global Financial Private Capital first reported a position in IBB in Q3 2017 and has held it in 10 quarters since. The position peaked at $469K in Q3 2018. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

Global Financial Private Capital held 100 shares of iShares Biotechnology ETF worth $14K as of Q2 2020.
Global Financial Private Capital bought 93 iShares Biotechnology ETF shares in Q2 2020, an estimated $11.9K.
iShares Biotechnology ETF made up ﹤0.01% of Global Financial Private Capital's portfolio in Q2 2020, its #294 holding.
Global Financial Private Capital first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 10 quarters since.
Global Financial Private Capital's iShares Biotechnology ETF position peaked at $469K in Q3 2018.
766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.